TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30367875

Group type: EXPERIMENTAL
Intervention: LifeWalker (LW)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard Rollator (SR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Participants' Predicate Device (PD)
Number of subjects: 30
Study: 30368038

Group type: EXPERIMENTAL
Intervention: Hydroxycarbamide (HC)
Number of subjects: 3649

Group type: EXPERIMENTAL
Intervention: Anagrelide (ANA)
Number of subjects: 3649

Group type: EXPERIMENTAL
Intervention: Both HC and ANA
Number of subjects: 3649

Group type: COMPARATOR
Intervention: HC
Number of subjects: 3649
Study: 30368548

Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam (4/0.5 g, tid) administered over 0.5 h
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (16 ICU patients)
Number of subjects: 20
Study: 30368788

Group type: EXPERIMENTAL
Intervention: Cannabidiol oral solution (standardized formulation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Various investigational compounds (anakinra, cannabidiol, cannabidivarin, fenfluramine, ganaxolone, medium-chain fatty acids, padsevonil, valnoctamide, sec-butylpropylacetamide)
Number of subjects: 0
Study: 30368871

Group type: EXPERIMENTAL
Intervention: Columbia-Suicide Severity Rating Scale (C-SSRS)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Baseline intensity subscale scores
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Baseline severity subscale scores
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Severity of ideation cutoff scores
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Prior behavior criterion
Number of subjects: 237
Study: 30369044

Group type: EXPERIMENTAL
Intervention: HPS6 genetic analysis and platelet electron microscopy
Number of subjects: 1

Group type: COMPARATOR
Intervention: Control cells
Number of subjects: 1
Study: 30369290

Group type: EXPERIMENTAL
Intervention: Anticoagulant therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 30369317

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 0
Study: 30370457

Group type: EXPERIMENTAL
Intervention: Aquablation for <100 cc prostates
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Aquablation for >100 cc prostates
Number of subjects: 101
Study: 30370468

Group type: EXPERIMENTAL
Intervention: Tocilizumab monotherapy (8 mg/kg)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Tocilizumab combined with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Tocilizumab monotherapy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Tocilizumab combined with csDMARDs
Number of subjects: 200
Study: 30370691

Group type: EXPERIMENTAL
Intervention: Composite estimand approach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment policy estimand
Number of subjects: 0
Study: 30371223

Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 737

Group type: COMPARATOR
Intervention: Not taking SSRIs (Control)
Number of subjects: 737

Group type: EXPERIMENTAL
Intervention: Rivaroxaban with SSRIs
Number of subjects: 737

Group type: EXPERIMENTAL
Intervention: Warfarin with SSRIs
Number of subjects: 737

Group type: EXPERIMENTAL
Intervention: SSRIs
Number of subjects: 737
Study: 30371285

Group type: EXPERIMENTAL
Intervention: MAGGIC risk score (mean ± SD of 18 ± 7)
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: MAGGIC risk score
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: MAGGIC risk score with B-type natriuretic peptide
Number of subjects: 407
Study: 30371301

Group type: EXPERIMENTAL
Intervention: Exenatide once-weekly
Number of subjects: 14752
Study: 30371728

Group type: EXPERIMENTAL
Intervention: Adapted ACC/AHA BPM procedure
Number of subjects: 805

Group type: COMPARATOR
Intervention: CHEP BPM procedure
Number of subjects: 805
Study: 30371784

Group type: EXPERIMENTAL
Intervention: Bidirectional cavopulmonary connection
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Total cavopulmonary connection
Number of subjects: 39

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both procedures
Number of subjects: 39
Study: 30372653

Group type: EXPERIMENTAL
Intervention: Therapist-rated working alliance
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Patient-rated alliance
Number of subjects: 73
Study: 30373560

Group type: EXPERIMENTAL
Intervention: Improved cookstoves offered at randomly varying prices to peers of households that had previously received stoves for free.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Improved cookstoves offered at randomly varying prices to non-peers of households that had previously received stoves for free.
Number of subjects: 0
Study: 30373600

Group type: EXPERIMENTAL
Intervention: microRNA array
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: TaqMan Real-time PCR
Number of subjects: 40
Study: 30373638

Group type: EXPERIMENTAL
Intervention: Therapeutic plasma exchange (TPE)
Number of subjects: 20
Study: 30373653

Group type: EXPERIMENTAL
Intervention: APPROVE (automated electronic health record-based model)
Number of subjects: 68875

Group type: EXPERIMENTAL
Intervention: APPROVE (threshold > 0.25)
Number of subjects: 68875

Group type: COMPARATOR
Intervention: MEWS (Modified Early Warning Score)
Number of subjects: 68875

Group type: COMPARATOR
Intervention: NEWS (National Early Warning Score)
Number of subjects: 68875

Group type: COMPARATOR
Intervention: MEWS and NEWS (threshold > 4)
Number of subjects: 68875
Study: 30373671

Group type: EXPERIMENTAL
Intervention: Childhood asthma (self-reported, diagnosed by a medical professional, onset < 16 years)
Number of subjects: 10199

Group type: COMPARATOR
Intervention: No history of asthma
Number of subjects: 10199

Group type: EXPERIMENTAL
Intervention: GWAS in NHW and AA populations
Number of subjects: 10199
Study: 30373683

Group type: EXPERIMENTAL
Intervention: Obstructive Sleep Apnea (OSA) severity
Number of subjects: 98

Group type: COMPARATOR
Intervention: Blood pressure control with medications
Number of subjects: 98
Study: 30373731

Group type: EXPERIMENTAL
Intervention: Active tDCS (2 mA for 20 minutes, 15 sessions)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Sham tDCS (2 mA for 20 minutes, 15 sessions)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 94

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 94
Study: 30373783

Group type: EXPERIMENTAL
Intervention: Management of severe ischaemic stroke
Number of subjects: 2500

Group type: EXPERIMENTAL
Intervention: Follow-up management of severe ischaemic stroke
Number of subjects: 2500
Study: 30373800

Group type: EXPERIMENTAL
Intervention: Therapeutic drug monitoring (TDM) with limited sampling strategies (LSSs)
Number of subjects: 0
Study: 30374460

Group type: EXPERIMENTAL
Intervention: Proton radiotherapy
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Lower pretreatment plasma HGF level
Number of subjects: 34
Study: 30374686

Group type: EXPERIMENTAL
Intervention: Bevacizumab (10 mg/kg, every 2 weeks) with temsirolimus (25 mg weekly)
Number of subjects: 39
Study: 30375693

Group type: EXPERIMENTAL
Intervention: Direct-acting antiviral therapy
Number of subjects: 191
Study: 30376863

Group type: EXPERIMENTAL
Intervention: GTP group
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: TTP group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control muscle (m. vastus lateralis)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: All groups (TTP, GTP, Control)
Number of subjects: 20
Study: 30377142

Group type: EXPERIMENTAL
Intervention: Mobile phone app for self-management of T1DM
Number of subjects: 154000
Study: 30377191

Group type: EXPERIMENTAL
Intervention: Oral Carnitine Challenge Test (OCCT)
Number of subjects: 57
Study: 30377436

Group type: EXPERIMENTAL
Intervention: Women with PCOS
Number of subjects: 86

Group type: COMPARATOR
Intervention: Women with T2DM
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Women with PCOS (inflexible)
Number of subjects: 86
Study: 30377537

Group type: EXPERIMENTAL
Intervention: Hatha yoga, implemented via twice weekly 60-min group-based classes for 12 weeks.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control group (no specific intervention details provided).
Number of subjects: 0
Study: 30377539

Group type: EXPERIMENTAL
Intervention: High neighborhood social disorganization
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: High neighborhood economic disadvantage
Number of subjects: 424

Group type: COMPARATOR
Intervention: Controlling for individual level variables
Number of subjects: 424
Study: 30377677

Group type: EXPERIMENTAL
Intervention: ω-3 fatty acid status testing
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Fatty fish intake
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: ω-3 supplement use
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Perceived ω-3 status
Number of subjects: 100
Study: 30377981

Group type: EXPERIMENTAL
Intervention: Standard of Care measure delivered through Qualtrics to HIV care providers
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Standard of Care measure
Number of subjects: 75
Study: 30377991

Group type: EXPERIMENTAL
Intervention: Erenumab (specific dosage and duration not mentioned)
Number of subjects: 0
Study: 30378520

Group type: EXPERIMENTAL
Intervention: Severe food insecurity among pregnant women
Number of subjects: 1230

Group type: EXPERIMENTAL
Intervention: Moderate food insecurity among pregnant women
Number of subjects: 1230

Group type: EXPERIMENTAL
Intervention: Mild, moderate, and severe food insecurity among lactating women
Number of subjects: 1230

Group type: EXPERIMENTAL
Intervention: Moderate and severe food insecurity among lactating women
Number of subjects: 1230

Group type: EXPERIMENTAL
Intervention: Food insecurity levels among lactating women
Number of subjects: 1230
Study: 30380032

Group type: EXPERIMENTAL
Intervention: Impaired endogenous fibrinolysis (baseline lysis time (LT) ≥2500 s)
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Impaired endogenous fibrinolysis
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Spontaneous ST-segment resolution pre-PPCI
Number of subjects: 496

Group type: COMPARATOR
Intervention: Standard of care STEMI treatment including DAPT
Number of subjects: 496
Study: 30380060

Group type: EXPERIMENTAL
Intervention: Ceftaroline fosamil 600 mg q12h by 1 h intravenous infusion
Number of subjects: 951

Group type: EXPERIMENTAL
Intervention: Ceftaroline fosamil 600 mg q8h by 2 h intravenous infusion
Number of subjects: 951
Study: 30380386

Group type: EXPERIMENTAL
Intervention: Hu5F9-G4 (5F9) antibody with rituximab
Number of subjects: 22
Study: 30381078

Group type: EXPERIMENTAL
Intervention: CT-707
Number of subjects: 2

Group type: COMPARATOR
Intervention: Crizotinib
Number of subjects: 2
Study: 30381282

Group type: EXPERIMENTAL
Intervention: Nutritional supplements (protein isolate powder, immunomodulation solution, carbohydrate loading)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Nutritional supplements
Number of subjects: 165
Study: 30382017

Group type: EXPERIMENTAL
Intervention: 18F-fluorodeoxyglucose (PET)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: 11C-raclopride (PET)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: 11C-FLB 457 (PET)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Neuropsychiatric tests
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: D2-receptor availability assessment
Number of subjects: 82
Study: 30382161

Group type: EXPERIMENTAL
Intervention: Sodium oxybate
Number of subjects: 0
Study: 30382850

Group type: EXPERIMENTAL
Intervention: Ceramic implants (PURE Ceramic Implant, Institut Straumann AG, Basel, Switzerland) with a diameter of 4.1 mm
Number of subjects: 44
Study: 30382910

Group type: EXPERIMENTAL
Intervention: Dental insurance
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Reporting a dental insurance barrier to care
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Higher motivation to visit the dentist
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Self-efficacy to visit the dentist
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Having a disability
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Higher education level
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Perceived gum disease
Number of subjects: 100

Group type: COMPARATOR
Intervention: Being married
Number of subjects: 100

Group type: COMPARATOR
Intervention: Not having a last dental cleaning within the past year
Number of subjects: 100
Study: 30382912

Group type: EXPERIMENTAL
Intervention: Community Profile Survey (CPS)
Number of subjects: 84
Study: 30382942

Group type: EXPERIMENTAL
Intervention: Daclatasvir+sofosbuvir+ribavirin for 24 weeks
Number of subjects: 78
Study: 30383134

Group type: EXPERIMENTAL
Intervention: Sildenafil 40 mg
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Sildenafil 80 mg
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 30383139

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 65093

Group type: EXPERIMENTAL
Intervention: Sleeve gastrectomy (SG)
Number of subjects: 65093

Group type: EXPERIMENTAL
Intervention: Adjustable gastric banding (AGB)
Number of subjects: 65093

Group type: COMPARATOR
Intervention: Roux-en-Y gastric bypass (RYGB) vs Sleeve gastrectomy (SG)
Number of subjects: 65093

Group type: COMPARATOR
Intervention: Roux-en-Y gastric bypass (RYGB) vs Adjustable gastric banding (AGB)
Number of subjects: 65093

Group type: COMPARATOR
Intervention: Sleeve gastrectomy (SG) vs Adjustable gastric banding (AGB)
Number of subjects: 65093
Study: 30383140

Group type: EXPERIMENTAL
Intervention: Imatinib, 400 mg once daily, orally for 5 years
Number of subjects: 91
Study: 30383276

Group type: EXPERIMENTAL
Intervention: Complementary Feeding Utility Index (CFUI) for 7-12 months
Number of subjects: 6000

Group type: EXPERIMENTAL
Intervention: Healthy Eating Index-2015 (HEI-2015) for 13 and 24 months
Number of subjects: 6000
Study: 30383277

Group type: EXPERIMENTAL
Intervention: Psychological-based acculturation
Number of subjects: 1194

Group type: EXPERIMENTAL
Intervention: Language-based scale
Number of subjects: 1194

Group type: EXPERIMENTAL
Intervention: Psychological-based scale
Number of subjects: 1194

Group type: EXPERIMENTAL
Intervention: Years living in the mainland United States
Number of subjects: 1194

Group type: EXPERIMENTAL
Intervention: Income >$25,000
Number of subjects: 1194

Group type: COMPARATOR
Intervention: No associations
Number of subjects: 1194
Study: 30383280

Group type: EXPERIMENTAL
Intervention: Lower saturated fat intake
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Increased vegetable and fruit intake
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Fiber intake
Number of subjects: 564
Study: 30383482

Group type: EXPERIMENTAL
Intervention: Employer wellness programs for obesity management
Number of subjects: 3008

Group type: EXPERIMENTAL
Intervention: Awareness and attitudes of employer representatives (ERs) regarding obesity management
Number of subjects: 3008

Group type: EXPERIMENTAL
Intervention: Challenges in implementing workplace wellness programs
Number of subjects: 3008
Study: 30383777

Group type: EXPERIMENTAL
Intervention: Benznidazole treatment (TrG)
Number of subjects: 493
Study: 30383781

Group type: EXPERIMENTAL
Intervention: Fasted posture
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Non-fasted posture
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Seated posture
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Fasting state
Number of subjects: 22
Study: 30384320

Group type: EXPERIMENTAL
Intervention: Civil commitment for opioid use
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Post-commitment medication treatment
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Perceived procedural justice during commitment hearing
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Positive attitude and higher motivation at the end of commitment
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Improvement in attitude during commitment
Number of subjects: 292
Study: 30384846

Group type: EXPERIMENTAL
Intervention: Past placental malaria exposure
Number of subjects: 313

Group type: COMPARATOR
Intervention: Non-exposed control group
Number of subjects: 313

Group type: EXPERIMENTAL
Intervention: TLR7/8 stimulation
Number of subjects: 313
Study: 30385437

Group type: EXPERIMENTAL
Intervention: Antihyperglycaemic medication
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Diabetes-related comorbidity and higher mental component summary score in the SF-36
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: General information needs
Number of subjects: 138
Study: 30386184

Group type: EXPERIMENTAL
Intervention: Management training and toolkit for community-based organizations (CBOs)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 31
Study: 30386416

Group type: EXPERIMENTAL
Intervention: Liver Qi Stagnation (LQS)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Heart and Spleen Deficiency (HSD)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Healthy Controls
Number of subjects: 50
Study: 30386591

Group type: EXPERIMENTAL
Intervention: Pulmonary artery catheter (PAC) use
Number of subjects: 6844
Study: 30386820

Group type: EXPERIMENTAL
Intervention: Computerized combined training (executive function and memory) for 96 sessions for more than 24 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: No intervention (waitlist control group)
Number of subjects: 120
Study: 30386824

Group type: EXPERIMENTAL
Intervention: MRgRT dose adaptation
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard IMRT
Number of subjects: 75
Study: 30386863

Group type: EXPERIMENTAL
Intervention: Body Composition Assessment
Number of subjects: 0
Study: 30387050

Group type: EXPERIMENTAL
Intervention: Early 7-day supplemental parenteral nutrition (SPN)
Number of subjects: 131
Study: 30387527

Group type: EXPERIMENTAL
Intervention: Narcolepsy type 1 (NT1) patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: ADNI group (control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: MAPT-AV45 group (control)
Number of subjects: 0
Study: 30388073

Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg
Number of subjects: 197

Group type: COMPARATOR
Intervention: Adalimumab 40 mg
Number of subjects: 197
Study: 30388108

Group type: EXPERIMENTAL
Intervention: Single oral dose of 400 mg albendazole (ALB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Microscopic (duplicate Kato-Katz thick smear, Mini-FLOTAC, FECPAKG2) and molecular stool-based diagnostic methods (quantitative PCR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DNA samples submitted for pyrosequencing
Number of subjects: 0
Study: 30388966

Group type: EXPERIMENTAL
Intervention: Prenatal exposure to extra vitamin D from food fortification
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prenatal exposure to extra vitamin D from food fortification (spring-born women)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unexposed women
Number of subjects: 0
Study: 30389034

Group type: EXPERIMENTAL
Intervention: R-CHOP-21
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: R-CHOP-14
Number of subjects: 300

Group type: COMPARATOR
Intervention: R-CHOP-21 and R-CHOP-14
Number of subjects: 300
Study: 30389348

Group type: EXPERIMENTAL
Intervention: Predominant pain mechanism classification by two assessors
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Predominant pain pattern classification by two assessors
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Predominant dysfunction pattern classification by two assessors
Number of subjects: 48
Study: 30389550

Group type: EXPERIMENTAL
Intervention: Carvedilol prophylaxis
Number of subjects: 106
Study: 30389624

Group type: EXPERIMENTAL
Intervention: Long-QST
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: NDS
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: NCS
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Small and medium fibers
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Large fiber deficits
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Complete loss of function in all fibers
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Hyperalgesia
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: NSS
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Age and albuminuria
Number of subjects: 136
Study: 30389646

Group type: EXPERIMENTAL
Intervention: Monthly motivational phone calls by a trained nutritionist and weekly tailored text messages over a 12-month period (high intervention uptake)
Number of subjects: 0
Study: 30389649

Group type: EXPERIMENTAL
Intervention: Online integrated treatment (8 weeks, 12 modules based on cognitive behavioral therapy and motivational interviewing)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Psychoeducational control group (links to resources, access to full treatment after follow-up)
Number of subjects: 214
Study: 30390114

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy with deep regional hyperthermia (HCRT)
Number of subjects: 112
Study: 30390170

Group type: EXPERIMENTAL
Intervention: Trastuzumab treatment
Number of subjects: 41
Study: 30390395

Group type: EXPERIMENTAL
Intervention: Ranolazine
Number of subjects: 0
Study: 30390672

Group type: EXPERIMENTAL
Intervention: Anti-TNF-α treatment pre-operatively (n=18)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Anti-TNF-α naïve patients (n=28)
Number of subjects: 46
Study: 30390698

Group type: EXPERIMENTAL
Intervention: Respiratory failure (RF)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Pupillary response
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Injury severity score (ISS)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Midline shift > 15 mm
Number of subjects: 100
Study: 30390896

Group type: EXPERIMENTAL
Intervention: Integrated Nutrition Pathway for Acute Care (INPAC) implementation
Number of subjects: 1250

Group type: EXPERIMENTAL
Intervention: Standard care activities implementation
Number of subjects: 1250
Study: 30391776

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 111

Group type: COMPARATOR
Intervention: Vitamin K-antagonist (VKA)
Number of subjects: 111
Study: 30391805

Group type: EXPERIMENTAL
Intervention: Insulin receptor-related genes and dopamine regulation-related genes in the dlPFC
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Insulin receptor-related genes and dopamine regulation-related genes in the hippocampus
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Insulin receptor gene (INSR)
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Insulin receptor substrate 1 and 2
Number of subjects: 321
Study: 30392095

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 9338

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9338